Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats

被引:67
作者
Zheng, Ping [1 ]
Niu, Feng-Li [1 ]
Liu, Wen-Zhong [1 ]
Shi, Yao [1 ]
Lu, Lun-Gen [1 ]
机构
[1] Shanghai Med Univ 2, Renji Hosp, Shanghai Inst Digest Dis, Shanghai 200127, Peoples R China
关键词
Oxymatrine; Colitis; Colonic mucosa;
D O I
10.3748/wjg.v11.i31.4912
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium (DSS)-induced colitis of rats. METHODS: Acute colitis was induced by giving 2% DSS orally in drinking water for 8 d. Twenty-six male rats were randomized into oxymatrine-treated group (group A, 10 rats), DSS control (group B, 10 rats) and normal control (group C, 6 rats). The rats in group A were injected muscularly with oxymatrine at the dosage of 63 mg/(kg.d) from d 1 to 11 and drank 2% DSS solution from d 4 to 11. The rats in group B were treated with 0.9% saline in an equal volume as group A and drank 2% DSS solution from d 4 to 11. The rats in group C were treated with 0.9% saline as group B from d 1 to 11 and drank water normally. Diarrhea and bloody stool as well as colonic histology were observed. The levels of serum tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) were determined by ELISA, and nuclear factor-kappa B (NF-kappa B) activity and the expression of inter-cellular adhesion molecule-1 (ICAM-1) in colonic mucosa were detected by immunohistochemistry method. RESULTS: Compared with DSS control group, the inflammatory symptoms and histological damages of colonic mucosa in oxymatrine-treated group were significantly improved, the serum levels of TNF-alpha, IL-6, and the expression of NF-kappa B, ICAM-1 in colonic mucosa were significantly reduced. CONCLUSION: The fact that oxymatrine can reduce the serum levels of TNF-alpha, IL-6, and the expression of NF-kappa B and ICAM-1 in colonic mucosa in DSS-induced colitis of rats indicates that oxymatrine may ameliorate the colonic inflammation and thus alleviate diarrhea and bloody stool. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:4912 / 4915
页数:4
相关论文
共 21 条
[1]   The transcription factor NF-κB and human disease [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :3-6
[2]   Detection of ICAM-1 in experimentally induced colitis of ICAM-1-deficient and wild-type mice:: An immunohistochemical study [J].
Bendjelloul, F ;
Rossmann, P ;
Maly, P ;
Mandys, V ;
Jirkovská, M ;
Prokesová, L ;
Tucková, L ;
Tlaskalová-Hogenová, H .
HISTOCHEMICAL JOURNAL, 2000, 32 (12) :703-709
[3]   Quantification of mucosal leucocyte endothelial cell interaction by in vivo fluorescence microscopy in experimental colitis in mice [J].
Farkas, S ;
Herfarth, H ;
Rössle, M ;
Schroeder, J ;
Steinbauer, M ;
Guba, M ;
Beham, A ;
Schölmerich, J ;
Jauch, KW ;
Anthuber, M .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 126 (02) :250-258
[4]   Nuclear factor-κB activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin [J].
Herfarth, H ;
Brand, K ;
Rath, HC ;
Rogler, G ;
Schölmerich, J ;
Falk, W .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (01) :59-65
[5]  
Hu ZL, 1996, ACTA PHARMACOL SIN, V17, P259
[6]   Mediation by NF-κB of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors [J].
Jobin, C ;
Hellerbrand, C ;
Licato, LL ;
Brenner, DA ;
Sartor, RB .
GUT, 1998, 42 (06) :779-787
[7]   Effects of germinated barley foodstuff on dextran sulfate sodium-induced colitis in rats [J].
Kanauchi, O ;
Nakamura, T ;
Agata, K ;
Mitsuyama, K ;
Iwanaga, T .
JOURNAL OF GASTROENTEROLOGY, 1998, 33 (02) :179-188
[8]  
Lin W., 1997, Yaoxue Xuebao, V32, P93
[9]   Dextran sulfate sodium-induced murine colitis activates NF-κB and increases galanin-1 receptor expression [J].
Marrero, JA ;
Matkowskyj, KA ;
Yung, K ;
Hecht, G ;
Benya, RV .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2000, 278 (05) :G797-G804
[10]  
Moriguchi M, 1999, ARZNEIMITTELFORSCH, V49, P184